The Metabolic Syndrome: A Lifestyle Medicine Foe Worthy of a Seek and Destroy Mission

American Journal of Lifestyle Medicine

Volumn 2, Issue 2, 2008, Pages 109-112

  Greenstone, Clinton L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

cardiovascular risk factors; metabolic syndrome

Indexed keywords

EID: 84990365102     PISSN: 15598276     EISSN: None     Source Type: Journal    
DOI: 10.1177/1559827607312261     Document Type: Article

References (18)

1. Grundy SM Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007; 92: 399-404.
2. Scherer PE Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006; 55: 1537-1545.
3. Liu J., Grundy SM, Wang W., et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J. 2007; 153: 552-558.
4. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346: 393-403.
5. Diet, genes, and transcriptional factors associated with the metabolic syndrome. Proceedings of the 6th Nestle Nutrition Conference, Mexico City, Mexico, November 16-17, 2006. Nutr Rev. 2007;65(6 pt 2):S1-S68.
6. Janiszewski PJ, Saunders TJ, Ross R. Lifestyle treatment of the metabolic syndrome. Am J Lifestyle Med. 2008; 2: 99-108.
7. Grundy SM Does the metabolic syndrome exist? Diabetes Care. 2006; 29: 1689-1692; discussion 1693-1696.
8. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-2497.
9. Alberti KG, Zimmet P., Shaw J. Metabolic syndrome: a new world-wide definition: a consensus statement from the International Diabetes Federation. Diabet Med. 2006; 23: 469-480.
10. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24: 683-689.
11. Lorenzo C., Okoloise M., Williams K., Stern MP, Haffner SM The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003; 26: 3153-3159.
12. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288: 2709-2716.
13. Grundy SM Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient? Am J Med. 2007; 120(9 suppl 1):S3-S8; discussion S9.
14. Liu J., Grundy SM, Wang W., et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J. 2007; 153: 552-558.
15. Janiszewski PM, Ross R. Physical activity in the treatment of obesity: beyond body weight reduction. Appl Physiol Nutr Metab. 2007; 32: 512-522.
16. Myers J., Prakash M., Froelicher V., Do D., Partington S., Atwood JE Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002; 346: 793-801.
17. Hayward RA, Hofer TP, Vijan S. Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med. 2006; 145: 520-530.
18. Nathan D. Trials that matter: rosiglitazone, ramipril and the prevention of type 2 diabetes. Ann Intern Med. 2007; 146: 461-463.